208 related articles for article (PubMed ID: 28299580)
41. FBXW7 induces apoptosis in glioblastoma cells by regulating HDAC7.
Nie X; Jia W; Li X; Pan X; Yin R; Liu N; Su Z
Cell Biol Int; 2021 Oct; 45(10):2150-2158. PubMed ID: 34288252
[TBL] [Abstract][Full Text] [Related]
42. HDAC7 promotes NSCLC proliferation and metastasis via stabilization by deubiquitinase USP10 and activation of β-catenin-FGF18 pathway.
Guo K; Ma Z; Zhang Y; Han L; Shao C; Feng Y; Gao F; Di S; Zhang Z; Zhang J; Tabbò F; Ekman S; Suda K; Cappuzzo F; Han J; Li X; Yan X
J Exp Clin Cancer Res; 2022 Mar; 41(1):91. PubMed ID: 35277183
[TBL] [Abstract][Full Text] [Related]
43. MicroRNA-10b promotes migration and invasion through Hoxd10 in human gastric cancer.
Wang YY; Li L; Ye ZY; Zhao ZS; Yan ZL
World J Surg Oncol; 2015 Aug; 13():259. PubMed ID: 26311318
[TBL] [Abstract][Full Text] [Related]
44. Distinct subgroup of the Ras family member 3 (DIRAS3) expression impairs metastasis and induces autophagy of gastric cancer cells in mice.
Qiu J; Li X; He Y; Sun D; Li W; Xin Y
J Cancer Res Clin Oncol; 2018 Oct; 144(10):1869-1886. PubMed ID: 30043279
[TBL] [Abstract][Full Text] [Related]
45. TPX2 expression is associated with poor survival in gastric cancer.
Tomii C; Inokuchi M; Takagi Y; Ishikawa T; Otsuki S; Uetake H; Kojima K; Kawano T
World J Surg Oncol; 2017 Jan; 15(1):14. PubMed ID: 28069036
[TBL] [Abstract][Full Text] [Related]
46. Dowregulation of OTX1 attenuates gastric cancer cell proliferation, migration and invasion.
Qin SC; Zhao Z; Sheng JX; Xu XH; Yao J; Lu JJ; Chen B; Zhao GD; Wang XY; Yang YD
Oncol Rep; 2018 Oct; 40(4):1907-1916. PubMed ID: 30066897
[TBL] [Abstract][Full Text] [Related]
47. SSH1 expression is associated with gastric cancer progression and predicts a poor prognosis.
Maimaiti Y; Maimaitiming M; Li Y; Aibibula S; Ainiwaer A; Aili A; Sun Z; Abudureyimu K
BMC Gastroenterol; 2018 Jan; 18(1):12. PubMed ID: 29338701
[TBL] [Abstract][Full Text] [Related]
48. Reduction of TIP30 correlates with poor prognosis of gastric cancer patients and its restoration drastically inhibits tumor growth and metastasis.
Li X; Zhang Y; Cao S; Chen X; Lu Y; Jin H; Sun S; Chen B; Liu J; Ding J; Wu K; Fan D
Int J Cancer; 2009 Feb; 124(3):713-21. PubMed ID: 18972434
[TBL] [Abstract][Full Text] [Related]
49. Correlation between survivin mRNA expression and lymph node metastasis in gastric cancer.
Miyachi K; Sasaki K; Onodera S; Taguchi T; Nagamachi M; Kaneko H; Sunagawa M
Gastric Cancer; 2003; 6(4):217-24. PubMed ID: 14716515
[TBL] [Abstract][Full Text] [Related]
50. Up-regulation of long non-coding RNA PCAT-1 correlates with tumor progression and poor prognosis in gastric cancer.
Cui WC; Wu YF; Qu HM
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(13):3021-3027. PubMed ID: 28742205
[TBL] [Abstract][Full Text] [Related]
51. MOR1 expression in gastric cancer: a biomarker associated with poor outcome.
Yao YS; Yao RY; Zhuang LK; Qi WW; Lv J; Zhou F; Qiu WS; Yue L
Clin Transl Sci; 2015 Apr; 8(2):137-42. PubMed ID: 25441763
[TBL] [Abstract][Full Text] [Related]
52. Aberrant expression of deubiquitylating enzyme USP9X predicts poor prognosis in gastric cancer.
Fu X; Xie W; Song X; Wu K; Xiao L; Liu Y; Zhang L
Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):687-692. PubMed ID: 28274596
[TBL] [Abstract][Full Text] [Related]
53. LncRNA ZEB1-AS1 predicts unfavorable prognosis in gastric cancer.
Li Y; Wen X; Wang L; Sun X; Ma H; Fu Z; Li L
Surg Oncol; 2017 Dec; 26(4):527-534. PubMed ID: 29113674
[TBL] [Abstract][Full Text] [Related]
54. NEDD9 overexpression correlates with poor prognosis in gastric cancer.
Liu Y; Wang D; Zhao KL; Zhu JW; Yin HB; Wei YZ; Wu ZJ; Cheng GJ; Wang F; Ni F; Wang XL; Cao GX; Huang J; Cai J
Tumour Biol; 2014 Jul; 35(7):6351-6. PubMed ID: 24664584
[TBL] [Abstract][Full Text] [Related]
55. MicroRNA-31 inhibits tumor invasion and metastasis by targeting RhoA in human gastric cancer.
Ge F; Wang C; Wang W; Liu W; Wu B
Oncol Rep; 2017 Aug; 38(2):1133-1139. PubMed ID: 28656284
[TBL] [Abstract][Full Text] [Related]
56. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.
Zhao Y; Zhang T; Wang Q
Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849
[TBL] [Abstract][Full Text] [Related]
57. Overexpression of Ras-GTPase-activating protein SH3 domain-binding protein 1 correlates with poor prognosis in gastric cancer patients.
Min L; Ruan Y; Shen Z; Jia D; Wang X; Zhao J; Sun Y; Gu J
Histopathology; 2015 Nov; 67(5):677-88. PubMed ID: 25809930
[TBL] [Abstract][Full Text] [Related]
58. Efficient isolation and proteomic analysis of cell plasma membrane proteins in gastric cancer reveal a novel differentiation and progression related cell surface marker, R-cadherin.
Chen B; Luo QC; Chen JB; Lin LE; Luo MX; Ren HY; Chen PQ; Shi LG
Tumour Biol; 2016 Sep; 37(9):11775-11787. PubMed ID: 27029387
[TBL] [Abstract][Full Text] [Related]
59. NT5E is associated with unfavorable prognosis and regulates cell proliferation and motility in gastric cancer.
Hu S; Meng F; Yin X; Cao C; Zhang G
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30992388
[TBL] [Abstract][Full Text] [Related]
60. MicroRNA-466 (miR-466) functions as a tumor suppressor and prognostic factor in colorectal cancer (CRC).
Tong F; Ying Y; Pan H; Zhao W; Li H; Zhan X
Bosn J Basic Med Sci; 2018 Aug; 18(3):252-259. PubMed ID: 29338680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
